Literature DB >> 32945884

Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin.

Mark F McCarty1, Aaron Lerner2.   

Abstract

Mitochondrial dysfunction in dopaminergic neurons of the substantia nigra (SN) appears to be a key mediating feature of Parkinson's disease (PD), a complex neurodegenerative disorder of still unknown etiology. Parkin is an E3 ubiquitin ligase that promotes mitophagy of damaged depolarized mitochondria while also boosting mitochondrial biogenesis-thereby helping to maintain efficient mitochondrial function. Boosting Parkin expression in the SN with viral vectors is protective in multiple rodent models of PD. Conversely, homozygosity for inactivating mutations of Parkin results in early-onset PD. Moderate protein plant-based diets relatively low in certain essential amino acids have the potential to boost Parkin expression by activating the kinase GCN2, which in turn boosts the expression of ATF4, a factor that drives transcription of the Parkin gene. Protein-restricted diets also upregulate the expression of PINK1, a protein that binds to the outer membrane of depolarized mitochondria and then recruits and activates Parkin. This effect of protein restriction is mediated by the downregulation of the kinase activity of mammalian target of rapamycin complex 1; the latter suppresses PINK1 expression at the transcriptional level. During the 20th century, cultures in East Asia and sub-Sahara Africa consuming quasi-vegan diets were found to be at notably decreased risk of PD compared with the USA or Europe. It is proposed that such diets may provide protection from PD by boosting Parkin and PINK1 expression in the SN. Other measures that might be expected to upregulate protective mitophagy include supplemental N-acetylcysteine (precursor for hydrogen sulfide) and a diet rich in spermidine-a polyamine notably high in corn.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  GCN2; PINK1; Parkinson's disease; mitochondrial dysfunction; mitophagy; nutraceuticals; nutritional therapy; parkin; quasi-vegan

Mesh:

Substances:

Year:  2021        PMID: 32945884      PMCID: PMC8009740          DOI: 10.1093/advances/nmaa112

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  125 in total

Review 1.  Sestrin regulation of TORC1: Is Sestrin a leucine sensor?

Authors:  Jun Hee Lee; Uhn-Soo Cho; Michael Karin
Journal:  Sci Signal       Date:  2016-06-07       Impact factor: 8.192

2.  AMPK Promotes Autophagy by Facilitating Mitochondrial Fission.

Authors:  Chen-Song Zhang; Sheng-Cai Lin
Journal:  Cell Metab       Date:  2016-03-08       Impact factor: 27.287

Review 3.  Environmental risk factors for Parkinson's disease: the epidemiologic evidence.

Authors:  B S Schoenberg
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

4.  Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D.

Authors:  Teng Sun; Wei Ding; Tao Xu; Xiang Ao; Tao Yu; Mengyang Li; Ying Liu; Xuejuan Zhang; Lin Hou; Jianxun Wang
Journal:  Antioxid Redox Signal       Date:  2019-09-26       Impact factor: 8.401

5.  Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health.

Authors:  Luigi Fontana; Nicole E Cummings; Sebastian I Arriola Apelo; Joshua C Neuman; Ildiko Kasza; Brian A Schmidt; Edda Cava; Francesco Spelta; Valeria Tosti; Faizan A Syed; Emma L Baar; Nicola Veronese; Sara E Cottrell; Rachel J Fenske; Beatrice Bertozzi; Harpreet K Brar; Terri Pietka; Arnold D Bullock; Robert S Figenshau; Gerald L Andriole; Matthew J Merrins; Caroline M Alexander; Michelle E Kimple; Dudley W Lamming
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

6.  GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets.

Authors:  Mark F McCarty
Journal:  Med Hypotheses       Date:  2014-06-24       Impact factor: 1.538

Review 7.  Beneficial Effects of Flavonoids Against Parkinson's Disease.

Authors:  Un Ju Jung; Sang Ryong Kim
Journal:  J Med Food       Date:  2018-02-07       Impact factor: 2.786

8.  Dietary protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding.

Authors:  D Maiter; T Fliesen; L E Underwood; M Maes; G Gerard; M L Davenport; J M Ketelslegers
Journal:  Endocrinology       Date:  1989-05       Impact factor: 4.736

Review 9.  Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications.

Authors:  Nattakarn Limphaibool; Piotr Iwanowski; Marte Johanne Veilemand Holstad; Dominik Kobylarek; Wojciech Kozubski
Journal:  Front Neurol       Date:  2019-06-19       Impact factor: 4.003

10.  Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetes.

Authors:  Munehiro Kitada; Yoshio Ogura; Itaru Monno; Jing Xu; Daisuke Koya
Journal:  Aging (Albany NY)       Date:  2020-03-06       Impact factor: 5.682

View more
  4 in total

1.  Inhibition of miR-421 Preserves Mitochondrial Function and Protects against Parkinson's Disease Pathogenesis via Pink1/Parkin-Dependent Mitophagy.

Authors:  Xiaolin Dong; Xianghua He; Li Yang; Qingyun Li; Yanming Xu
Journal:  Dis Markers       Date:  2022-05-10       Impact factor: 3.464

2.  Cross-Reactivity and Sequence Homology Between Alpha-Synuclein and Food Products: A Step Further for Parkinson's Disease Synucleinopathy.

Authors:  Aristo Vojdani; Aaron Lerner; Elroy Vojdani
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

Review 3.  Mitochondria-Microbiota Interaction in Neurodegeneration.

Authors:  Peter Kramer
Journal:  Front Aging Neurosci       Date:  2021-12-23       Impact factor: 5.750

Review 4.  "Let Food Be Thy Medicine": Gluten and Potential Role in Neurodegeneration.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.